Pediatrix Medical [MD] vs Surgery Partners [SGRY] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Pediatrix Medical Group, Inc. wins in 14 metrics, Surgery Partners Inc. wins in 6 metrics, with 0 ties. Pediatrix Medical Group, Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Pediatrix Medical Group, Inc. | Surgery Partners Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 11.88 | 2,956.00 | Pediatrix Medical Group, Inc. |
| Price-to-Book Ratio | 2.16 | 1.09 | Surgery Partners Inc. |
| Debt-to-Equity Ratio | 73.29 | 114.51 | Pediatrix Medical Group, Inc. |
| PEG Ratio | 9.90 | -34.35 | Pediatrix Medical Group, Inc. |
| EV/EBITDA | 7.92 | 11.42 | Pediatrix Medical Group, Inc. |
| Profit Margin (TTM) | 8.64% | -2.35% | Pediatrix Medical Group, Inc. |
| Operating Margin (TTM) | 11.07% | 15.09% | Surgery Partners Inc. |
| EBITDA Margin (TTM) | 11.07% | 15.09% | Surgery Partners Inc. |
| Return on Equity | 20.28% | 2.76% | Pediatrix Medical Group, Inc. |
| Return on Assets (TTM) | 6.57% | 3.74% | Pediatrix Medical Group, Inc. |
| Free Cash Flow (TTM) | $252.63M | $195.60M | Pediatrix Medical Group, Inc. |
| 1-Year Return | 73.57% | -32.67% | Pediatrix Medical Group, Inc. |
| Price-to-Sales Ratio (TTM) | 1.00 | 0.57 | Surgery Partners Inc. |
| Enterprise Value | $2.00B | $7.49B | Surgery Partners Inc. |
| EV/Revenue Ratio | 1.05 | 2.26 | Pediatrix Medical Group, Inc. |
| Gross Profit Margin (TTM) | 25.51% | 23.98% | Pediatrix Medical Group, Inc. |
| Revenue per Share (TTM) | $23 | $26 | Surgery Partners Inc. |
| Earnings per Share (Diluted) | $1.94 | $-0.61 | Pediatrix Medical Group, Inc. |
| Beta (Stock Volatility) | 0.72 | 1.99 | Pediatrix Medical Group, Inc. |
| Short % of Float | 6.00% | 22.70% | Pediatrix Medical Group, Inc. |
Pediatrix Medical Group, Inc. vs Surgery Partners Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Pediatrix Medical Group, Inc. | 0.29% | 8.46% | 8.36% | 25.04% | 7.40% | 14.47% |
| Surgery Partners Inc. | -1.18% | 9.24% | 8.46% | 22.11% | -2.01% | -0.85% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Pediatrix Medical Group, Inc. | 73.57% | 75.20% | -20.69% | -64.71% | -31.34% | 9.12% |
| Surgery Partners Inc. | -32.67% | -62.68% | -76.34% | -2.17% | -16.93% | -16.93% |
Performance & Financial Health Analysis: Pediatrix Medical Group, Inc. vs Surgery Partners Inc.
| Metric | MD | SGRY |
|---|---|---|
| Market Information | ||
| Market Cap | $1.91B | $1.86B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 510,889 | 864,264 |
| 90 Day Avg. Volume | 755,756 | 1,150,188 |
| Last Close | $24.37 | $15.13 |
| 52 Week Range | $11.84 - $24.99 | $11.41 - $24.10 |
| % from 52W High | -2.48% | -37.22% |
| All-Time High | $86.09 (Aug 17, 2015) | $69.58 (Jun 21, 2021) |
| % from All-Time High | -71.69% | -78.26% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.02% |
| Quarterly Earnings Growth | 0.11% | 0.02% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | -0.02% |
| Operating Margin (TTM) | 0.11% | 0.15% |
| Return on Equity (TTM) | 0.20% | 0.03% |
| Debt to Equity (MRQ) | 73.29 | 114.51 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $10.68 | $13.37 |
| Cash per Share (MRQ) | $6.16 | $1.87 |
| Operating Cash Flow (TTM) | $271.09M | $274.30M |
| Levered Free Cash Flow (TTM) | $190.33M | $164.71M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Pediatrix Medical Group, Inc. vs Surgery Partners Inc.
| Metric | MD (Apr 26, 2026) | SGRY (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 11.88 | 2,956.00 |
| Forward P/E | 9.90 | 37.68 |
| PEG Ratio | 9.90 | -34.35 |
| Price to Sales (TTM) | 1.00 | 0.57 |
| Price to Book (MRQ) | 2.16 | 1.09 |
| Market Capitalization | ||
| Market Capitalization | $1.91B | $1.86B |
| Enterprise Value | $2.00B | $7.49B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.05 | 2.26 |
| Enterprise to EBITDA | 7.92 | 11.42 |
| Risk & Other Metrics | ||
| Beta | 0.72 | 1.99 |
| Book Value per Share (MRQ) | $10.68 | $13.37 |
Financial Statements Comparison: Pediatrix Medical Group, Inc. vs Surgery Partners Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | MD (2025) | SGRY (2025) |
|---|---|---|
| Revenue/Sales | 1.91B | 3.31B |
| Cost of Goods Sold | 1.42B | 2.54B |
| COGS % of Revenue | 74.2% | 76.9% |
| Gross Profit | 493.70M | 765.00M |
| Gross Margin | 25.8% | 23.1% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 231.09M | 470.80M |
| Operating Margin | 12.1% | 14.2% |
| EBITDA | 256.55M | 678.40M |
| EBITDA Margin | 13.4% | 20.5% |
| Pre-Tax Income | 216.43M | 116.90M |
| Pre-Tax Income % of Revenue | 11.3% | 3.5% |
| Income Tax | 51.04M | 18.00M |
| Income Tax % of Revenue | 2.7% | 0.5% |
| Net Income (Profit) | 165.39M | 98.90M |
| Profit Margin | 8.6% | 3.0% |
Balance Sheet & Liquidity Metrics
| Metric | MD (2025) | SGRY (2025) |
|---|---|---|
| Cash & Equivalents | 375.24M | 239.90M |
| Total Current Assets | 763.51M | 1.15B |
| Total Current Assets % of Revenue | 39.9% | 34.8% |
| Total Current Liabilities | 458.91M | 615.50M |
| Total Current Liabilities % of Revenue | 24.0% | 18.6% |
| Long-Term Debt | 596.22M | 3.88B |
| Long-Term Debt % of Revenue | 31.2% | 117.4% |
| Total Shareholders Equity | 865.85M | 3.53B |
| Retained Earnings | -83.15M | -815.20M |
| Retained Earnings % of Revenue | -4.3% | -24.6% |
| Property, Plant & Equipment | 195.53M | 1.60B |
Cash Flow Statement Comparison
| Metric | MD (2025) | SGRY (2025) |
|---|---|---|
| Operating Cash Flow | 270.23M | 243.40M |
| Operating Cash Flow % of Revenue | 14.1% | 7.4% |
| Capital Expenditures | -18.46M | -32.20M |
| Free Cash Flow | 252.63M | 195.60M |
| FCF Margin | 13.2% | 5.9% |
| Debt Repayment | -20.75M | -1.04B |
| Common Stock Repurchase | -86.68M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MD | SGRY |
|---|---|---|
| Shares Short | 3.53M | 14.00M |
| Short Ratio | 3.77 | 7.57 |
| Short % of Float | 6.00% | 22.70% |
| Shares Outstanding | 82.98M | 129.32M |
| Float Shares | 79.95M | 55.54M |
| % Held by Insiders | 2.31% | 1.53% |
| % Held by Institutions | 106.63% | 122.23% |
| % Held by Public | -8.94% | -23.76% |
Dividend Analysis & Yield Comparison: Pediatrix Medical Group, Inc. vs Surgery Partners Inc.
| Metric | MD | SGRY |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |